UBS Group upgraded shares of Calumet Specialty Products Partners (NASDAQ:CLMT - Free Report) from a sell rating to a neutral rating in a research note published on Monday morning, Marketbeat.com reports. UBS Group currently has $12.00 price target on the oil and gas company's stock, down from their previous price target of $15.00.
CLMT has been the subject of a number of other research reports. StockNews.com raised Calumet Specialty Products Partners to a "sell" rating in a research note on Monday, November 18th. Wells Fargo & Company reduced their price target on shares of Calumet Specialty Products Partners from $29.00 to $28.00 and set an "overweight" rating for the company in a research report on Wednesday, March 5th. HC Wainwright restated a "buy" rating and set a $33.00 price objective on shares of Calumet Specialty Products Partners in a report on Monday, March 3rd. Finally, TD Cowen lowered shares of Calumet Specialty Products Partners from a "buy" rating to a "hold" rating and lowered their target price for the stock from $26.00 to $16.00 in a report on Tuesday, March 4th. One analyst has rated the stock with a sell rating, two have issued a hold rating and three have assigned a buy rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of "Hold" and a consensus target price of $20.80.
Check Out Our Latest Stock Report on Calumet Specialty Products Partners
Calumet Specialty Products Partners Trading Down 4.9 %
NASDAQ CLMT traded down $0.66 on Monday, hitting $12.72. 3,139,857 shares of the company were exchanged, compared to its average volume of 695,633. The company has a market cap of $1.09 billion, a PE ratio of -4.61 and a beta of 1.88. The stock has a fifty day moving average of $15.55 and a 200-day moving average of $18.65. Calumet Specialty Products Partners has a 12 month low of $9.97 and a 12 month high of $25.29.
Calumet Specialty Products Partners (NASDAQ:CLMT - Get Free Report) last released its quarterly earnings data on Friday, February 28th. The oil and gas company reported ($0.47) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($1.06) by $0.59. The company had revenue of $949.50 million for the quarter, compared to the consensus estimate of $921.76 million. During the same period last year, the company earned ($0.59) EPS. Calumet Specialty Products Partners's revenue for the quarter was down 2.8% compared to the same quarter last year. On average, analysts expect that Calumet Specialty Products Partners will post -3.02 earnings per share for the current year.
Insider Buying and Selling at Calumet Specialty Products Partners
In other Calumet Specialty Products Partners news, CFO David Lunin acquired 2,500 shares of the company's stock in a transaction on Tuesday, March 4th. The shares were acquired at an average cost of $13.05 per share, with a total value of $32,625.00. Following the completion of the acquisition, the chief financial officer now directly owns 2,500 shares in the company, valued at $32,625. This trade represents a ∞ increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 2.91% of the stock is owned by corporate insiders.
About Calumet Specialty Products Partners
(
Get Free Report)
Calumet, Inc engages in the manufacturing, formulating, and marketing of a diversified slate of specialty branded products and renewable fuels to customers across a broad range of consumer-facing and industrial markets. It operates through the following segments: Specialty Products & Solutions, Performance Brands, Montana/Renewables, and Corporate.
Featured Articles

Before you consider Calumet Specialty Products Partners, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Calumet Specialty Products Partners wasn't on the list.
While Calumet Specialty Products Partners currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for April 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.